MedTrace Logo

Endometrial Receptivity Profile in Patients With Endometrial Proliferation Defects

NCT02406690 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2017-12-02

No results posted yet for this study

Summary

The purpose of this study is to determine the differences that exist in RNA molecules, the biochemical process of methylation, and estrogen receptor binding in patients that have failed to produce adequate endometrium in synthetic embryo transfer cycles when compared to patients whose endometrium thickness is within normal limits.

Conditions

  • Endometrial Dysfunction

Interventions

OTHER

Estradiol Valerate, Progesterone in Oil, Leuprolide

Patients will undergo a Leuprolide endometrial preparatory cycle using estradiol valerate, progesterone in oil and once completed will have a uterine aspiration and biopsy performed.

Sponsors & Collaborators

  • Reproductive Medicine Associates of New Jersey

    lead OTHER

Principal Investigators

  • Richard T Scott, Jr., MD, HCLD · Reproductive Medicine Associates of New Jersey

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2015-09-17
Completion
2015-09-17

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02406690 on ClinicalTrials.gov